About this episode
It’s become a multibillion-dollar business: weight loss drugs. Demand is high, as is the cost. How did medications like Ozempic, Wegovy, Mounjaro and Zepbound become so popular and so profitable? And what kind of impact might they have on the future of food and healthcare? Dr. Sanjay Gupta turns to his CNN colleague Meg Tirrell for answers, and a little context about the business behind these new medications.
Learn more about your ad choices. Visit podcastchoices.com/adchoices
Get every episode summarized
Each time Chasing Life publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Chasing Life
Why GLP-1s May or May Not Be for You
Chasing Life
May 1, 202631:24failed
Autism Doesn’t End at Childhood. Here’s the Reality
Chasing Life
Apr 28, 202616:40failed
What You’ve Wanted to Know About Autism but Were Too Afraid to Ask
Chasing Life
Apr 24, 202630:06failed
What Happens When Mom-To-Be Smokes Weed While Pregnant?
Chasing Life
Apr 21, 202618:39failed